Viewing Study NCT05616793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-03-06 @ 2:31 PM
Study NCT ID: NCT05616793
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Sponsor: Opus Genetics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None LCA5 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LCA View
None Retinal Degeneration View
None IRD View
None adeno associated virus View
None gene therapy View
None LCA5 View